• Open Daily: 10am - 10pm
    Alley-side Pickup: 10am - 7pm

    3038 Hennepin Ave Minneapolis, MN
    612-822-4611

Open Daily: 10am - 10pm | Alley-side Pickup: 10am - 7pm
3038 Hennepin Ave Minneapolis, MN
612-822-4611
Carbapenem-resistant Enterobacteriaceae urinary tract infections

Carbapenem-resistant Enterobacteriaceae urinary tract infections

Paperback

Medical Reference

ISBN10: 6207993446
ISBN13: 9786207993444
Publisher: Our Knowledge Publishing
Published: Aug 27 2024
Pages: 104
Weight: 0.36
Height: 0.25 Width: 6.00 Depth: 9.00
Language: English
The aim of our work is to describe the particularities of carbapenem-resistant Enterobacteriaceae (CRE) urinary tract infections as well as the selection factors of these resistant strains. This is a retrospective descriptive study including all patients hospitalized within the wards of CHU Taher Sfar Mahdia (2015- 2018) who had presented with ERC urinary tract infection. Twenty-three patients were collected. Their mean age was 57.3 years, with a sex ratio M/F=0.77. The infection was healthcare-associated in 56.5% of cases. The main risk factors for acquiring CRF were: previous antibiotic therapy (beta-lactams), previous hospitalization, an invasive procedure within the previous six months respectively, and a history of UTI within the previous year. The most frequently isolated germ was Klebsiella pneumoniae (69.5%). A combination of antibiotics was indicated in 19 cases (82.6%). Prescription of tigecycline was significantly associated with an unfavorable outcome (p=0.032). Intervention strategies need to be integrated, targeting decision-makers, prescribers and patients alike.

Also from

Bougossa, Rebeh

Also in

Medical Reference